GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medley 4480.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,455

+6.97%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥36.79bn

FY2017FY2025

Net income

¥975.0m

FY2017FY2025

Free cash flow

¥3.28bn

FY2017FY2025

Shareholders' equity

¥14.80bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥36.79bn¥29.30bn¥20.53bn¥14.19bn¥10.86bn¥6.83bn¥4.77bn¥2.93bn¥1.71bn
Gross profit¥23.19bn¥18.92bn¥13.59bn¥9.72bn¥6.99bn¥4.67bn¥3.21bn¥1.85bn¥1.17bn
Research and development¥72.0m¥69.0m¥9.0m¥6.0m¥34.9m¥67.5m¥4.6m——
Operating income¥2.30bn¥2.33bn¥2.70bn¥1.33bn¥780.2m¥413.4m¥153.2m−¥101.8m¥30.0m
Net income¥975.0m¥2.80bn¥2.57bn¥1.02bn¥563.0m¥456.0m−¥381.2m−¥153.6m¥35.7m
Diluted earnings per share28.7485.4978.5930.8317.3814.73-13.32-5.051.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥41.25bn¥45.41bn¥25.52bn¥21.81bn¥20.33bn¥15.65bn¥5.40bn¥2.31bn¥1.76bn
Cash and short-term investments¥8.57bn¥19.00bn¥15.35bn¥14.42bn¥14.29bn¥14.05bn¥4.48bn¥1.66bn¥1.42bn
Total liabilities¥26.45bn¥25.19bn¥7.89bn¥6.64bn¥6.28bn¥5.93bn¥2.04bn¥1.22bn¥532.9m
Debt¥16.09bn¥15.18bn¥1.66bn¥2.44bn¥3.11bn¥4.18bn¥963.4m¥538.6m¥100.0m
Shareholders' equity¥14.80bn¥20.21bn¥17.55bn¥15.08bn¥13.97bn¥9.72bn¥3.36bn¥1.09bn¥1.23bn
Shares outstanding34m33m33m33m32m31m29m30m30m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥3.49bn¥2.45bn¥3.87bn¥2.01bn¥1.04bn¥805.8m¥514.0m¥192.4m¥153.6m
Capital spending−¥205.0m−¥66.0m−¥403.0m−¥378.0m−¥242.5m−¥213.9m−¥167.2m−¥199.6m−¥118.0m
Free cash flow¥3.28bn¥2.38bn¥3.47bn¥1.64bn¥796.4m¥591.9m¥346.8m−¥7.2m¥35.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥12.49bn¥10.19bn¥9.25bn¥9.07bn¥10.32bn¥8.14bn¥7.66bn¥6.94bn
Gross profit¥8.21bn¥5.61bn¥5.79bn¥5.90bn¥6.68bn¥4.82bn¥4.93bn¥4.32bn
Operating income¥2.51bn−¥67.0m¥538.0m¥150.0m¥1.58bn−¥121.0m−¥31.0m¥97.0m
Net income¥1.56bn−¥62.0m−¥139.0m¥467.0m¥722.0m−¥75.0m¥474.0m¥315.0m
Diluted earnings per share51.30-2.04-4.1013.7721.29-2.2114.489.62
Total assets¥45.38bn¥43.68bn¥41.25bn¥43.10bn¥47.42bn¥48.97bn¥45.41bn¥41.13bn
Cash and short-term investments¥12.04bn¥10.99bn¥8.57bn¥10.53bn¥13.52bn¥14.15bn¥19.00bn¥18.76bn
Debt¥18.83bn¥4.79bn¥16.09bn¥3.89bn¥18.27bn¥4.60bn¥3.62bn¥3.20bn
Shareholders' equity¥14.96bn¥13.06bn¥14.80bn¥16.30bn¥18.07bn¥18.50bn¥20.21bn¥19.74bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue37.4%40.0%—
Operating income19.9%41.0%—
Net income-1.4%16.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.7%64.9%65.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings82.044.956.0127.5136.4308.3-97.3
Price to sales2.24.37.09.17.120.67.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.